Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Inhaled Insulin discontinued

According to an article on the PharmaTimes website, Inhaled Insulin marketed as Exubera® is being pulled from the market for commercial reasons.

Despite some heavy promotional activity the product has failed to make any impact in the diabetes market. According to PharmaTimes, this decision will cost the manufacturer $2.8 billion in terms of current inventory stock, fixed assets and exit costs in addition to the $1.3 billion already paid back in 2006 to ensure sole marketing rights to the drug.

Action: Patients who are currently being treated with inhaled insulin will need to be moved to an alternative treatment within the next three months.

Share 'Inhaled Insulin discontinued' on Email Share 'Inhaled Insulin discontinued' on Delicious Share 'Inhaled Insulin discontinued' on Digg Share 'Inhaled Insulin discontinued' on Facebook Share 'Inhaled Insulin discontinued' on Google+ Share 'Inhaled Insulin discontinued' on reddit Share 'Inhaled Insulin discontinued' on StumbleUpon Share 'Inhaled Insulin discontinued' on Twitter

atomic-wealth

No Comments to “Inhaled Insulin discontinued”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,615 spam comments.

atomic-wealth
fond-illness
summer